Cardlytics (CDLX) Announces Stock Repurchase Program

Cardlytics (NASDAQ: CDLX) (the “Company”), a digital advertising platform, today announced that its Board of Directors has approved the repurchase of up to an aggregate of $40.0 million of its Common Stock.

“We believe that the repurchase program is a good investment of available funds and underscores our commitment to enhancing shareholder value,” said Cardlytics CFO, Andy Christiansen.

The repurchases will be made from time to time on the open market at prevailing market prices or in negotiated transactions off the market. The repurchase program is expected to continue through the end of the current fiscal year unless extended or shortened by the Board of Directors.

The repurchase program does not obligate the Company to acquire any particular amount of ordinary shares, and the repurchase program may be suspended or discontinued at any time at the Company’s discretion.

You May Also Be Interested In

• Zymeworks raises 2026 guidance after closing Theravance acquisition
• GOWell Energy Technology begins trading on Nasdaq as NASDAQ: GOW
• CervoMed reports new neflamapimod tablet data, FDA lifts exposure cap